I cannot believe Leo isn’t in regular communication with reps from Big Pharmas. With BrilAcidin in human trials “across the globe” and with FDA granting the IND applicationI, FDA Fast Track, RBL testing to justify the trial, top Pharma would be negligent if they didn’t have their eye on IPIX. The odds if brilacidn meeting all trial goals are very high.